Exagen Inc.
XGN
$3.35
$0.020.60%
09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | 09/30/2023 | |
---|---|---|---|---|---|
Revenue | 55.75M | 56.66M | 55.73M | 52.55M | 51.62M |
Total Other Revenue | -- | -- | -- | -- | -- |
Total Revenue | 55.75M | 56.66M | 55.73M | 52.55M | 51.62M |
Cost of Revenue | 22.97M | 23.16M | 22.98M | 23.09M | 23.78M |
Gross Profit | 32.78M | 33.51M | 32.75M | 29.46M | 27.84M |
SG&A Expenses | 43.39M | 44.60M | 46.09M | 47.43M | 48.02M |
Depreciation & Amortization | -- | -- | -- | -- | -- |
Other Operating Expenses | -- | -- | -- | -- | -- |
Total Operating Expenses | 71.15M | 72.47M | 73.87M | 75.39M | 77.90M |
Operating Income | -15.40M | -15.81M | -18.13M | -22.84M | -26.28M |
Income Before Tax | -16.89M | -17.28M | -19.33M | -23.66M | -32.75M |
Income Tax Expenses | 33.00K | 33.00K | 33.00K | 33.00K | -282.00K |
Earnings from Continuing Operations | -16.93 | -17.31 | -19.36 | -23.69 | -32.47 |
Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
Minority Interest in Earnings | -- | -- | -- | -- | -- |
Net Income | -16.93M | -17.31M | -19.36M | -23.69M | -32.47M |
EBIT | -15.40M | -15.81M | -18.13M | -22.84M | -26.28M |
EBITDA | -13.58M | -13.81M | -16.06M | -20.67M | -24.10M |
EPS Basic | -0.94 | -0.97 | -1.09 | -1.34 | -1.86 |
Normalized Basic EPS | -0.59 | -0.60 | -0.68 | -0.84 | -0.96 |
EPS Diluted | -0.94 | -0.97 | -1.09 | -1.34 | -1.86 |
Normalized Diluted EPS | -0.59 | -0.60 | -0.68 | -0.84 | -0.96 |
Average Basic Shares Outstanding | 72.21M | 71.65M | 71.13M | 70.71M | 70.07M |
Average Diluted Shares Outstanding | 72.21M | 71.65M | 71.13M | 70.71M | 70.07M |
Dividend Per Share | -- | -- | -- | -- | -- |
Payout Ratio | -- | -- | -- | -- | -- |